The United States Adult Vaccine Market is projected to soar to US$ 11.10 billion by 2033, up from US$ 6.55 billion in 2024, ...

Infectious disease researchers found the vaccine, used to prevent herpes zoster, or shingles, is also linked to lower risks ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 1 study titled ‘A Study to Learn About ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 4 study titled ‘A Phase 4 Study Using a ...

Vaccine awareness, safety, and addressing misinformation are all important to improve adherence and public health outcomes, ...

In addition to the flu vaccine, the recently updated COVID-19 vaccine and the RSV vaccine are available, as well as vaccines against other illnesses.

Several observational analyses suggest higher cardiovascular and dementia risks in those with and without HIV who get ...

Findings presented at IDWeek 2025 underscore the importance of considering serotypes that disproportionately impact adults in the U.S. and show greater resistance to commonly prescribed ...

The shingles vaccine may help lower a person's risk for vascular dementia by 50% and cardiovascular events like blood clots, ...

Researchers found that COVID-19 mRNA vaccines, when given within 100 days of starting immune checkpoint inhibitors, were ...

Health experts warn that the lung infection can strike anyone — and often goes underrecognized. The screen legend died earlier this month from the condition.

Shingles vaccine recipients who had a breakthrough infection experienced no reduction in all-cause dementia compared with those who received a pneumonia vaccine. They trended toward fewer post-zoster ...